Table 3

Multivariate-adjusted HR (95% CI) of hyperglycaemia among BMI categories in stratified analyses

MHNWMHOWMHOP interaction
Gender<0.001
 Male1.00 (Ref.)1.11 (1.03 to 1.20)1.32 (1.15 to 1.51)
 Female1.00 (Ref.)1.43 (1.29 to 1.58)1.88 (1.52 to 2.32)
Age (years)0.534
 <401.00 (Ref.)1.32 (1.17 to 1.48)1.51 (1.21 to 1.89)
 ≥401.00 (Ref.)1.22 (1.13 to 1.31)1.53 (1.34 to 1.75)
Family history of diabetes0.290
 Yes1.00 (Ref.)1.23 (1.15 to 1.30)1.46 (1.30 to 1.65)
 No1.00 (Ref.)1.05 (0.71 to 1.55)2.12 (1.07 to 4.19)
Height (cm)1.31 (1.16 to 1.47)1.75 (1.38 to 2.21)0.056
 ≤161.901.00 (Ref.)1.31 (1.16 to 1.47)1.75 (1.38 to 2.21)
 162.00–169.901.00 (Ref.)1.26 (1.13 to 1.40)1.33 (1.07 to 1.64)
 ≥170.001.00 (Ref.)1.15 (1.04 to 1.26)1.50 (1.26 to 1.78)
  • Adjusted for gender (except gender subgroup), age (except age subgroup), family history of diabetes (except ‘family history of diabetes’ subgroup) and baseline FPG, ALT, AST, BUN, SCr, smoking status and drinking status.

  • ALT, alanine transaminase; AST, aspartate transaminase; BMI, body mass index; BUN, blood urea nitrogen; FPG, fasting plasma glucose; MHNW, metabolic healthy normal weight; MHO, metabolically healthy obesity; MHOW, metabolically healthy overweight; SCr, serum creatinine.